Acute Ischemic Stroke

ALAMEDA, Calif., July 7, 2026 Penumbra, Inc., a global leader in thrombectomy technologies, has announced the first patient enrollment...

ALAMEDA, Calif., June 11, 2026 Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance...

Taipei, Taiwan — February 6, 2026 Lumosa Therapeutics has announced positive Phase 2 clinical trial outcomes for LT3001 (odatroltide),...